ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Blackwell on Late Recurrences in Patients With Breast Cancer

Kimberly L. Blackwell, MD
Published: Thursday, Mar 10, 2016



Kimberly L. Blackwell, MD, medical oncologist, Duke Cancer Institute, discusses using the word "cure" in patients with breast cancer who have not had recurrences of disease.

Though it would be ideal to tell patients they are cured of their disease at 5 or 10 years, Blackwell is hesitant because there are several cases of late recurrences, she explains. Patients are always at risk for their cancer returning.

Blackwell is also cautious of primary breast cancer developing, which is often overlooked. The percentage of early-stage breast cancer survivors continues to increase; however, the same amount of patients are at risk for a new breast cancer.

<<< View more from the 33rd Annual Miami Breast Cancer Conference



Kimberly L. Blackwell, MD, medical oncologist, Duke Cancer Institute, discusses using the word "cure" in patients with breast cancer who have not had recurrences of disease.

Though it would be ideal to tell patients they are cured of their disease at 5 or 10 years, Blackwell is hesitant because there are several cases of late recurrences, she explains. Patients are always at risk for their cancer returning.

Blackwell is also cautious of primary breast cancer developing, which is often overlooked. The percentage of early-stage breast cancer survivors continues to increase; however, the same amount of patients are at risk for a new breast cancer.

<<< View more from the 33rd Annual Miami Breast Cancer Conference


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x